Moreira L F, Kenmotsu M, Gochi A, Tanaka N, Orita K
First Department of Surgery, Okayama University Medical School, Japan.
Cancer Detect Prev. 1999;23(2):123-8. doi: 10.1046/j.1525-1500.1999.09908.x.
We have previously demonstrated that lymphovascular infiltration was correlated with an increased risk for developing lymph node metastasis in rectal adenocarcinomas confined within the submucosal layer. In another study, lymphovascular infiltration was also correlated with poor prognosis for patients with advanced rectal cancers. Considerations that low rectal tumors have an increased risk to develop recurrence and neural invasion have been recently implicated with a more localized pattern of tumor spread. We therefore assessed the lymphovascular and neural invasion in 65 specimens from patients with low rectal cancers who underwent curative operation to determine its implications in the treatment and prognosis. Lymphovascular invasion was noted in 60%, and neural invasion was found in 27% of the cases. Five-year survival rates (Kaplan-Meier method) were significantly decreased in patients with lymphovascular invasion (31 vs. 67%; p < 0.01) or neural invasion (30 vs. 58%; p < 0.01). Neither lymphovascular nor neural invasion was noted in Dukes' stage A tumors. There was no recurrence or distant metastasis in these patients. However, lymphovascular and neural invasion increased with tumor stage. Local recurrence and distant metastasis occurred respectively in three and four, and five and five patients with Dukes' B and C tumors, respectively. Both Dukes' B and C cases with local recurrence had a higher incidence of neural invasion as compared with the disease-free group. These results suggest that postoperative assessment of venous and neural invasion may provide valuable information to better determine which patients with low rectal cancers would benefit from adjuvant treatment.
我们之前已经证明,在局限于黏膜下层的直肠腺癌中,淋巴管浸润与发生淋巴结转移的风险增加相关。在另一项研究中,淋巴管浸润也与晚期直肠癌患者的不良预后相关。最近有观点认为,低位直肠癌发生复发和神经侵犯的风险增加,与肿瘤更局限的扩散模式有关。因此,我们评估了65例接受根治性手术的低位直肠癌患者标本中的淋巴管和神经侵犯情况,以确定其对治疗和预后的影响。60%的病例发现有淋巴管侵犯,27%的病例发现有神经侵犯。淋巴管侵犯(31%对67%;p<0.01)或神经侵犯(30%对58%;p<0.01)患者的五年生存率(Kaplan-Meier法)显著降低。Dukes A期肿瘤未发现淋巴管或神经侵犯。这些患者没有复发或远处转移。然而,淋巴管和神经侵犯随肿瘤分期增加。Dukes B期和C期肿瘤分别有3例和4例、5例和5例发生局部复发和远处转移。与无病组相比,发生局部复发的Dukes B期和C期病例神经侵犯发生率更高。这些结果表明,术后评估静脉和神经侵犯可能为更好地确定哪些低位直肠癌患者将从辅助治疗中获益提供有价值的信息。